Placebo nasal spray
Placebo nasal spray is an intervention with 59 clinical trials. Currently 6 active trials ongoing. Historical success rate of 89.4%.
Success Metrics
Based on 42 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
16
Mid Stage
31
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.4%
42 of 51 finished
17.6%
9 ended early
6
trials recruiting
59
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)
The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)
Clinical Trials (59)
Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)
The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)
PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2
A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure
PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge
Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)
Target Engagement and Response to Oxytocin
A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine
rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19
An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma
Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)
Oxytocin and Cognitive Control in Adult ADHD
Oxytocin on Cold Water Task Performance and Recovery
Oxytocin for Oxidative Stress and Inflammation
Efficacy and Safety of Azeol Nasal Spray Versus Placebo in the Treatment of Early Symptoms of Common Cold in Adults
Compare the Efficacy and Safety of Intranasal Esketamine in Chronic Opioid Refractory Pain
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 59